Works matching IS 21938261 AND DT 2024 AND VI 13 AND IP 4

Results: 11

Milvexian: An Oral, Bioavailable Factor XIa Inhibitor.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 645, doi. 10.1007/s40119-024-00379-0

By:

Parsa, Shyon;
Jain, Sneha S.;
Akinrimisi, Olu;
Lam, Carolyn S. P.;
Mahaffey, Kenneth W.

Publication type:

Article

Expert Opinion on the Role of Sacubitril/Valsartan in the Management of Hypertension in India.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 663, doi. 10.1007/s40119-024-00390-5

By:

Jadhav, Uday M.;
Ray, Saumitra;
Unni, T. Govindan;
Sawhney, J. P. S.;
Mehta, Ashwani;
Guha, Shantanu;
Karnik, Rajiv D.;
Desai, Bhupen N.;
Khan, Aziz;
Patel, Keyur;
Prajapati, Jayesh S.;
Shah, Hitesh J.;
Reddy, Rama Krishna;
Kumar, Sanjeev;
Dutta, Soumya Kanti;
Chakraborty, Saujatya;
Ahmed, Ashfaque;
Prasad, Ravi Vishnu;
Chaudhary, Gaurav;
Kumar, Amit

Publication type:

Article

Real-World Application of Evolocumab Among Patients with Hyperlipidemia in Korea: A Multicenter Prospective Study.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 695, doi. 10.1007/s40119-024-00389-y

By:

Kim, Min Chul;
Lee, Seung Hun;
Ahn, Joon Ho;
Lim, Yongwhan;
Park, Kyung-il;
Kim, Choongki;
Ahn, Jong-Hwa;
Jeong, JinSeon;
Lee, Hojoon;
Kang, Woong Chol

Publication type:

Article

Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 797, doi. 10.1007/s40119-024-00388-z

By:

Williams, Rhys;
Ford, William;
James, Alexander;
Thomas, Kerys;
Wong, Aaron

Publication type:

Article

Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 761, doi. 10.1007/s40119-024-00387-0

By:

Amoey, Danial;
Samy, Mohamed;
Elbasha, Karim;
Alali, Ahmad;
Landt, Martin;
Kurniadi, Arief;
Nef, Holger;
Tölg, Ralph;
Richardt, Gert;
Mankerious, Nader

Publication type:

Article

Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 775, doi. 10.1007/s40119-024-00386-1

By:

Chin, Kelly M.;
Channick, Richard;
Kim, Nick H.;
Ong, Rose;
Turricchia, Stefano;
Martin, Nicolas;
Mitchell, Lada;
McLaughlin, Vallerie V.

Publication type:

Article

National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 679, doi. 10.1007/s40119-024-00385-2

By:

Thyagaturu, Harshith;
Ali, Shafaqat;
Seetharam, Karthik;
Upreti, Prakash;
Doddi, Akshith;
Atti, Lalitsiri;
Roma, Nicholas;
Lacoste, Jordan L.;
Angirekula, Aakash;
Salami, Joseph;
Nasir, Khurram;
Balla, Sudarshan

Publication type:

Article

Asia–Pacific Real-World Evolocumab Use, LDL-C Reduction, Physician Goals, and Patient Perceptions: HALES Observational Study.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 737, doi. 10.1007/s40119-024-00384-3

By:

Tse, Hung-Fat;
Chang, Hung-Yu;
Colquhoun, David;
Kim, Jung-Sun;
Poh, Kian Keong;
Kostner, Karam;
Hutayanon, Pisit;
Cho, Meejin;
Lange, Jeff;
Kodiappan, Kamlanathan;
Leekha, Saikiran

Publication type:

Article

A Response to: Letter to the Editor Regarding "Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)".

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 815, doi. 10.1007/s40119-024-00383-4

By:

Attal, Sepideh

Publication type:

Article

Letter to the Editor Regarding 'Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)'.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 811, doi. 10.1007/s40119-024-00382-5

By:

Kristen, Arnt V.;
Tschöpe, Carsten;
Schwarting, Stephanie;
Siepen, Fabian aus dem

Publication type:

Article

ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.

Published in:

Cardiology & Therapy, 2024, v. 13, n. 4, p. 707, doi. 10.1007/s40119-024-00381-6

By:

Sobhy, Mohamed;
Eletriby, Adel;
Ragy, Hany;
Kandil, Hossam;
Saleh, Mohamed Ayman;
Farag, Nabil;
Guindy, Ramez;
Bendary, Ahmed;
Nayel, Ahmed Mohamed Elmahmoudy;
Shawky, Ahmed;
Khairy, Ayman;
Mortada, Ayman;
Zarif, Bassem;
Badran, Haitham;
Khorshid, Hazem;
Mahmoud, Kareem;
Said, Karim;
Leon, Khaled;
Abdelsabour, Mahmoud;
Tawfik, Mazen

Publication type:

Article